Plain-English translation of NCT05629494 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether ibuprofen can help clarify confusing prostate screening results. When prostate screening tests come back elevated, doctors often aren't sure if this means cancer or just temporary inflammation. This study compares two approaches: waiting six weeks and retesting, or taking ibuprofen 400 mg three times daily for six weeks and then retesting, to see which method gives clearer answers.
Right now, about half of the biopsies doctors perform based on elevated screening results don't find cancer—but patients still face the risks and stress of the procedure. This medication approach could help avoid unnecessary, invasive procedures by more accurately determining which elevated results truly warrant further testing.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to one of two groups: either you'll wait six weeks and have your prostate screening test repeated, or you'll take ibuprofen 400 mg three times daily for six weeks and then have your test repeated. The study is designed to compare how these two approaches help clarify whether your elevated screening result truly needs further investigation. Your participation lasts about six weeks from enrollment to your follow-up test.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States